PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes (Q27320965)
Jump to navigation
Jump to search
scientific article (publication date: 2013)
Language | Label | Description | Also known as |
---|---|---|---|
English | PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes |
scientific article (publication date: 2013) |
Statements
PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes (English)
0 references
2013
0 references
8
0 references
1
0 references
e53709
0 references
15 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference